Theriva Biologics Inc (TOVX)
0.4195
+0.01
(+2.33%)
USD |
NYAM |
Apr 26, 16:00
0.4199
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Shareholders Equity (Quarterly): 39.70M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 39.70M |
September 30, 2023 | 43.88M |
June 30, 2023 | 47.75M |
March 31, 2023 | 50.59M |
December 31, 2022 | 54.56M |
September 30, 2022 | 58.15M |
June 30, 2022 | 61.67M |
March 31, 2022 | 68.03M |
December 31, 2021 | 65.41M |
September 30, 2021 | 73.33M |
June 30, 2021 | 76.50M |
March 31, 2021 | 79.60M |
December 31, 2020 | 8.031M |
September 30, 2020 | 6.682M |
June 30, 2020 | 8.703M |
March 31, 2020 | 11.48M |
December 31, 2019 | 14.36M |
September 30, 2019 | 17.41M |
June 30, 2019 | 22.44M |
March 31, 2019 | 25.88M |
December 31, 2018 | 29.36M |
September 30, 2018 | 8.501M |
June 30, 2018 | 5.686M |
March 31, 2018 | 8.926M |
December 31, 2017 | 10.56M |
Date | Value |
---|---|
September 30, 2017 | -4.788M |
June 30, 2017 | 4.83M |
March 31, 2017 | 2.569M |
December 31, 2016 | 3.845M |
September 30, 2016 | -4.476M |
June 30, 2016 | 2.294M |
March 31, 2016 | 6.258M |
December 31, 2015 | 16.05M |
September 30, 2015 | 25.87M |
June 30, 2015 | -13.66M |
March 31, 2015 | -1.625M |
December 31, 2014 | 9.556M |
September 30, 2014 | 3.757M |
June 30, 2014 | 8.057M |
March 31, 2014 | 11.76M |
December 31, 2013 | 15.23M |
September 30, 2013 | 6.369M |
June 30, 2013 | 9.398M |
March 31, 2013 | 11.49M |
December 31, 2012 | 13.03M |
September 30, 2012 | 5.409M |
June 30, 2012 | 6.85M |
March 31, 2012 | 7.906M |
December 31, 2011 | 7.059M |
September 30, 2011 | 8.439M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.682M
Minimum
Sep 2020
79.60M
Maximum
Mar 2021
42.54M
Average
47.75M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Oragenics Inc | 3.168M |
Nanoviricides Inc | 12.45M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 55.22M |
Total Liabilities (Quarterly) | 15.52M |